The Judicial Panel on
Multi-District Litigation has consolidated nearly two dozen Xarelto cases. An
MDL is now set up in the United States District Court for the Eastern District
of Louisiana with Judge Fallon presiding. Judge Eldon Fallon is very familiar
with the MDL process as he is the presiding Judge over the Chinese Drywall MDL and presided over the Vioxx MDL.
Lawyers for the Plaintiffs argued
that any consolidation should occur in either St. Louis under Judge Freda
Wolfson, who is presiding over the Pradaxa MDL, or sent to New Jersey. The
Defendants, Johnson & Johnson subsidiary Jannsen Pharmaceuticals and Bayer,
argued against consolidation.
Xarelto (rivaroxaban) is an oral
blood thinner medication used to reduce the risk of blood clots and strokes in
patients with atrial fibrillation and to treat blood clots in the leg and
lungs. However, unlike other blood thinners like Coumadin, Xarelto does not
have reversal agents to counteract its anticoagulation effects, according to
the FDA.
Pittman, Dutton & Hellums,
P.C., is currently investigating Xarelto cases. If you or a loved one were
prescribed Xarelto and suffered an irreversible internal bleeding that lead to
hospitalization and/or death, contact Booth Samuels at toll free 1-866-515-8880
or by email at booths@pittmanudutton.com.
